These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27344744)

  • 1. [Inquiry and physical examination (including digital rectal examination) for patients with prostate cancer].
    Ishidoya S
    Nihon Rinsho; 2016 May; 74 Suppl 3():291-4. PubMed ID: 27344744
    [No Abstract]   [Full Text] [Related]  

  • 2. Digital rectal examination can detect early prostate cancer.
    Roobol MJ
    Evid Based Med; 2015 Jun; 20(3):119. PubMed ID: 25758963
    [No Abstract]   [Full Text] [Related]  

  • 3. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.
    Walsh AL; Considine SW; Thomas AZ; Lynch TH; Manecksha RP
    Br J Gen Pract; 2014 Dec; 64(629):e783-7. PubMed ID: 25452543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is routine digital rectal examination required for the followup of prostate cancer?
    Warren KS; McFarlane JP
    J Urol; 2007 Jul; 178(1):115-9. PubMed ID: 17499293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of prostate cancer].
    Strittmatter F
    MMW Fortschr Med; 2010 May; 152(19):40-2. PubMed ID: 20557001
    [No Abstract]   [Full Text] [Related]  

  • 6. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.
    Jentzmik F; Stephan C; Miller K; Schrader M; Erbersdobler A; Kristiansen G; Lein M; Jung K
    Eur Urol; 2010 Jul; 58(1):12-8; discussion 20-1. PubMed ID: 20117878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inquiry and physical examination (including digital rectal examination) for patients with prostate cancer].
    Ishidoya S
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():228-31. PubMed ID: 22207977
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer.
    Galić J; Karner I; Cenan L; Tucak A; Hegedus I; Pasini J; Bilandzija-Peranović M; Mihaljević S
    Coll Antropol; 2003; 27 Suppl 1():61-6. PubMed ID: 12955893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical decisions. Prostate cancer screening--polling results.
    Colbert JA; Adler JN
    N Engl J Med; 2012 Oct; 367(17):e25. PubMed ID: 23094752
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen testing and prostate cancer screening.
    Djavan B; Eckersberger E; Finkelstein J; Sadri H; Taneja SS; Lepor H
    Prim Care; 2010 Sep; 37(3):441-59, vii. PubMed ID: 20705192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 14. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostatic disease.
    Gupta S; Pound CR
    J Miss State Med Assoc; 2013 Sep; 54(9):255-7. PubMed ID: 24371903
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Horwich A; Parker C; de Reijke T; Kataja V;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi106-14. PubMed ID: 23813930
    [No Abstract]   [Full Text] [Related]  

  • 18. Guideline of guidelines: prostate cancer screening.
    Loeb S
    BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical decisions. Screening for prostate cancer.
    D'Amico AV; Smith MR
    N Engl J Med; 2012 Aug; 367(7):e11. PubMed ID: 22894598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PSA screening--medically useful or superfluous?].
    Glatz U
    Dtsch Med Wochenschr; 2010 Jan; 135(4):p3. PubMed ID: 20101552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.